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Interleukin-6 (IL-6) is a cytokine that has a wide variety of biological activities involved in the immune response, acute inflammation and haematopoiesis (Kishimoto, 1989) . The cell types producing IL-6 are systemically distributed: T-cells, Bcells, monocytes, fibroblasts, keratinocytes, endothelial cells, and several tumour cells (Ray et al., 1989) . production in T-cells is induced by T-cell mitogens such as phorbol esters or concanavalin A and antigenic stimulation on direct contact with macrophages (Horii et al., 1988) . Several T-cell lines, however, transformed by human T-cell lymphotropic virus type I (HTLV-I) express IL-6 mRNA without stimulation (Hirano et al., 1986; Noma et al., 1989) . Adult T-cell leukaemia (ATL) is causally associated with HTLV-I infection and some ATL-cells produce or respond to lymphokines such as IL-1 (Kodaka et al., 1989) , (Tsuda & Takatsuki, 1983; Arima et al., 1987) , and IL-4 (Uchiyama et al., 1988) .
In this study, we attempted to elucidate whether ATL-cells secrete Table I . Furthermore, T-cell enriched preparations were obtained by a sheep red blood cell rosetting technique (Tsuda & Takatsuki, 1984 (1-2 x 107 u mg-') and polyclonal anti human IL-6 antibody were obtained from Amersham (Arlington Heights, IL, USA) and R & D Systems (Minneapolis, MN, USA), respectively. An ELISA kit (Inter-Test 6, Genzyme Corporation, Boston, MA, USA) was used for the measurement of IL-6 in sera and conditioned media (CMs).
First, the sera of both healthy volunteers (n = 6) and ATL patients of different types or phases of disease (Kawano et al., 1985) ; acute (n = 9), chronic (n = 10), smouldering (n = 7), and lymphoma (n = 1) type, were tested for IL-6 levels. In the case of ATL, the patients with sepsis or endotoxemia were omitted because serum IL-6 levels are known to be enhanced in such conditions (Hack et al., 1989) .
Results showed that not only control sera but also ATL sera from all four categories of ATL patient did not have detectable levels of IL-6 (data not shown) (limit of sensitivity is 0.163 ng ml1' or 0.815 u ml-').
Next, in order to clarify whether ATL-cells do secrete IL-6 in vitro, CMs sampled at 2, 4, 8 and 24 h following culture were tested for IL-6 concentrations. As shown in Figure 1 and 24 h, and the case secreting the largest amount of IL-6 (ATL 1) was positive by 4 h. Another two cases (ATL 3 and 4) showed slightly higher IL-6 levels than controls at 8 and 24 h, but the last two cases (ATL 5 and 7) did not show detectable levels of IL-6 even at 24 h. It is known that IL-6 mRNA is induced in monocytes and T-cells within 5 h and 24-48 h after culture initiation, respectively (Kishimoto, 1989) . Considering the high purity of ATL cells used in the study (Table I ) and early detection of IL-6 at 4 or 8 h of culture, the large amount of IL-6 detected in ATL-CMs seemed to be secreted by ATL cells themselves. However, normal T cells contaminated in the T cell preparations, if activated, could have contributed some of the IL 6 that was secreted into their cultures.
IL-6 promotes the growth of PHA-stimulated thymocytes and peripheral T-cells (Kishimoto, 1989) . To examine whether the IL-6 enhances proliferation of ATL-cells, ATL from patients 1, 2, 5, 6 and 7 were incubated in the presence of IL-6 (20 ng ml-') or anti-IL-6 antibody (200 u ml-') for 72 h; proliferation was measured by 3H-thymidine (3H-TdR) incorporation in the last 16 h of culture. The 3H-TdR uptake into ATL-cells was not influenced by either IL-6 or anti-IL-6 antibody (Table II) .
Thus, we have demonstrated that ATL cells from four out of six patients secreted IL-6 spontaneously in vitro and that IL-6 was not detected in the sera of ATL patients in different phases of the disease. HTLV-I infection activates genes for (I x 106ml-') were incubated for indicated periods of time. IL-6 levels in conditioned media were determined by ELISA in duplicates following the instructions of the manufacturer. The horseradish peroxidase-mediated colour reaction was measured by substracting absorbance at 650 nm (A. 650) from that at 492 nm (A. 492). The screened columns represent ranges of IL-6 levels in normal T-cell-CM (mean ± s.d., n = 4). The broken line show the lower limit of absorbance which can be converted to IL-6 concentration using standard curve. The closed circle shows IL-6 concentrations in complete medium used in cell culture. Values beside each point indicate calculated IL-6 concentrations (ng ml-'). (D Macmillan Press Ltd., 1990 Br. J. Cancer (1990 aThe cells were stained by the direct or indirect immunofluorescence technique using monoclonal antibodies; OKT1 1, OKT3, OKT4, OKT8, OKNK, Bi or anti Tac, then analysed by flow cytometer (Cytoron, Ortho Diagnostic Systems, Tokyo, Japan) as described previously (Tsuda & Takatsuki, 1983 , 1984 . bnot tested.
various cytokines and their receptors, but cytokine production is not solely regulated by the virus genome (Noma et al., 1989) . Multiple elements induced in T-cells by HTLV-I infection seem to contribute to the production of IL-6. The gene for IL-6 is located in chromosome 7p2l (Sehgel et al., 1986) .
As the frequent chromosomal abnormalities of ATL are observed in chromosome 7 (Ueshima et al., 1981) , it is intriguing to speculate on the presence of a relationship between chromosome 7 abnormality and unregulated production of IL-6 presented in this study. Despite in vitro overproduction of IL-6 by ATL-cells, we could not show detectable levels of IL-6 in the sera of ATL patients. Although the reason for this discrepancy is unclear, a more sensitive assay could show enhanced IL-6 levels in ATL sera. 3H-TdR incorporation by ATL-cells was not affected by IL-6 or anti-IL-6 antibody added exogenously. Nevertheless, it is still possible that IL-6 may play an important role in the growth of ATL-cells in vivo since reportedly induced IL-2 and IL-2 receptor expression in normal T-cells (Garman et al., 1987; Tosato & Pike, 1988; Noma et al., 1987) . However, our preliminary data suggest that expression of IL-2 receptor on ATL cells was not apparently affected by either IL-6 or anti-IL-6 antibody (data not shown). In ATL, an autocrine mechanism through IL-2 and IL-2 receptor is still in debate (Tsuda & Takatsuki, 1983; Uchiyama et al., 1985; Arima et al., 1987) . The clinical features that accompany ATL are diverse. Some of them may be explained by IL-6 production by ATL cells, such as the frequently observed elevation of C-reactive protein (CRP), accelerated erythrocyte sedimentation rate (ESR) and thrombocytosis (Castell et al., 1989; Lotem et al., 1989) . Thus unregulated IL-6 production by ATL cells may be involved not only in pathogenesis but also in major clinical manifestations of the disease. aGne unit (u) anti-IL-6 corresponds to titre to neutralise 1 u IL-6; bNot tested.
